257 related articles for article (PubMed ID: 24144760)
1. [Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1521-4. PubMed ID: 24144760
[TBL] [Abstract][Full Text] [Related]
2. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
[TBL] [Abstract][Full Text] [Related]
3. Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats.
Yamaguchi S; Inada C; Tamura M; Sato N; Yamada M; Itaba S; Okazaki S; Matsuura H; Fujii S; Matsuda F; Goto Y; Mochizuki H; Kurumatani H; Miyamoto M
Eur J Pharmacol; 2013 Aug; 714(1-3):325-31. PubMed ID: 23911885
[TBL] [Abstract][Full Text] [Related]
4. Effects of non-surgical periodontal therapy on the glomerular filtration rate of the kidney: an exploratory trial.
Graziani F; Cei S; La Ferla F; Vano M; Gabriele M; Tonetti M
J Clin Periodontol; 2010 Jul; 37(7):638-43. PubMed ID: 20500539
[TBL] [Abstract][Full Text] [Related]
5. Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model.
Yamada M; Sasaki R; Sato N; Suzuki M; Tamura M; Matsushita T; Kurumatani H
Eur J Pharmacol; 2002 Aug; 449(1-2):167-76. PubMed ID: 12163121
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis].
Zhong WQ; Liu GX; Yang YM; Cai X; Huang ZL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):292-4. PubMed ID: 15132795
[TBL] [Abstract][Full Text] [Related]
7. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
Wang YJ; He LQ; Sun W; Lu Y; Wang XQ; Zhang PQ; Wei LB; Cao SL; Yang NZ; Ma HZ; Gao J; Li P; Tao XJ; Yuan FH; Li J; Yao C; Liu X
J Ethnopharmacol; 2012 Feb; 139(3):757-64. PubMed ID: 22178174
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effect of defibrase in chronic glomerulonephritis with chronic renal failure].
Wu JF; Wang SH
Zhonghua Nei Ke Za Zhi; 1989 Mar; 28(3):171-3, 188. PubMed ID: 2805953
[TBL] [Abstract][Full Text] [Related]
9. Beraprost Sodium Protects Against Diabetic Nephropathy in Patients with Arteriosclerosis Obliterans: A Prospective, Randomized, Open-label Study.
Shima A; Miyamoto M; Kubota Y; Takagi G; Shimizu W
J Nippon Med Sch; 2015; 82(2):84-91. PubMed ID: 25959199
[TBL] [Abstract][Full Text] [Related]
10. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
12. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
14. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
15. Relationship of hepatic and renal dysfunction with haemorrheological parameters in Plasmodium falciparum malaria.
Misra DP; Das S; Pattnaik M; Singh SC; Jena RK
J Assoc Physicians India; 2011 Sep; 59():552-6. PubMed ID: 22334967
[TBL] [Abstract][Full Text] [Related]
16. A prostacyclin analog prevents the regression of renal microvascular network by inhibiting mitochondria-dependent apoptosis in the kidney of rat progressive glomerulonephritis.
Goto Y; Yamaguchi S; Tamura M; Mochizuki H; Kurumatani H; Okano K; Miyamoto M
Prostaglandins Other Lipid Mediat; 2014 Aug; 112():16-26. PubMed ID: 24992870
[TBL] [Abstract][Full Text] [Related]
17. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
[TBL] [Abstract][Full Text] [Related]
18. [[Effect of erythropoietin and its combination with hypoxic altitude chamber training on the clinical and functional manifestations of chronic glomerulonephritis].
Kaliev R; Murkamilov IT; Fomin VV; Kaliev KP; Aver'ianova NI
Ter Arkh; 2014; 86(10):40-6. PubMed ID: 25509891
[TBL] [Abstract][Full Text] [Related]
19. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
Ciabattoni G; Cinotti GA; Pierucci A; Simonetti BM; Manzi M; Pugliese F; Barsotti P; Pecci G; Taggi F; Patrono C
N Engl J Med; 1984 Feb; 310(5):279-83. PubMed ID: 6361565
[TBL] [Abstract][Full Text] [Related]
20. [Effects of alprostadil in prevention of portal vein thrombogenesis after splenectomy and devascularization: a clinical observation of 76 patients with portal hypertension].
Ma JC; Zhao J; Su QH; Zhang DH; Guo Y; Ji ZZ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):524-6. PubMed ID: 18649766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
